Home  |  Contact

UniProtKB/Swiss-Prot O60733: Variant p.Arg550Trp

85/88 kDa calcium-independent phospholipase A2
Gene: PLA2G6
Chromosomal location: 22q13.1
Variant information

Variant position:  550
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Polymorphism
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Arginine (R) to Tryptophan (W) at position 550 (R550W, p.Arg550Trp).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and basic (R) to large size and aromatic (W)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  550
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  806
The length of the canonical sequence.

Location on the sequence:   HSKSMAYMRGMYFRMKDEVF  R GSRPYESGPLEEFLKREFGE
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         HSKSMAYMRGMYFRMKDEVFRGSRPYESGPLEEFLKREFGE

Mouse                         HSKSMAYMRGVYFRMKDEVFRGSRPYESGPLEEFLKREFGE

Rat                           HSKSMAYMRGVYFRMKDEVFRGSRPYESGPLEEFLKREFGE

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 806 85/88 kDa calcium-independent phospholipase A2
Domain 481 – 665 PNPLA
Alternative sequence 480 – 806 Missing. In isoform Ankyrin-iPLA2-1.
Alternative sequence 500 – 806 Missing. In isoform Ankyrin-iPLA2-2.


Literature citations

Mutations in KARS cause early-onset hearing loss and leukoencephalopathy: Potential pathogenic mechanism.
Zhou X.L.; He L.X.; Yu L.J.; Wang Y.; Wang X.J.; Wang E.D.; Yang T.;
Hum. Mutat. 38:1740-1750(2017)
Cited for: VARIANT TRP-550;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.